학술논문
Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group
Document Type
Article
Author
Source
In European Journal of Cancer 2004 40(5):689-695
Subject
Language
ISSN
0959-8049